Radical Pericardiectomy and Use of Cardiopulmonary Bypass for Constrictive Pericarditis

Marijan Koprivanac1, Karolis Bauza1, Nicholas Smedira1

  • 1Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio.

PubMed

Insights

Radical pericardiectomy significantly improves survival and hemodynamic function in constrictive pericarditis patients compared to partial resection. This definitive treatment offers better long-term outcomes with acceptable surgical risk.

Area of Science:

  • Cardiovascular Surgery
  • Thoracic Surgery
  • Cardiac Surgery

Background:

  • Pericardiectomy is the definitive treatment for constrictive pericarditis.
  • Debate exists regarding the optimal extent of pericardiectomy (radical vs. partial) and the use of cardiopulmonary bypass (CPB).

Purpose of the Study:

  • To compare hemodynamic changes, complications, and long-term survival between radical and partial pericardiectomy.
  • To evaluate the impact of cardiopulmonary bypass (CPB) use in pericardiectomy for constrictive pericarditis.

Main Methods:

  • A retrospective analysis of 534 adult patients undergoing pericardiectomy for constrictive pericarditis from 2000-2022.
  • Propensity-matched analysis of 89 pairs comparing radical (n=425) versus partial (n=109) pericardiectomy, assessing hemodynamic parameters, complications, and mortality.

Main Results:

  • Radical pericardiectomy led to a greater increase in cardiac index and decrease in central venous pressure compared to partial resection (P<.001).
  • Operative mortality was significantly lower after radical pericardiectomy (3.4% vs. 17%, P=.0029).
  • Ten-year survival was substantially higher with radical pericardiectomy (62% vs. 23%), with no difference in survival based on CPB use.

Conclusions:

  • Radical pericardiectomy is associated with improved early and long-term survival for constrictive pericarditis.
  • The procedure can be performed with low surgical mortality and morbidity, even with cardiopulmonary bypass use.
Abstract

Related Concept Videos

Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
276
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
310
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
431
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
422
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
360
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
251